Source: Business Standard

ViiV Healthcare: GSK's HIV venture fails to get USFDA approval for once-a-month injection

ViiV Healthcare received a complete response letter from the Food and Drug Administration, which cited "chemistry manufacturing and controls," according to a statement from the HIV unit

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Estimated Annual Revenue

Estimated Employees

Deborah Waterhouse's photo - CEO of ViiV Healthcare

CEO

Deborah Waterhouse

CEO Approval Rating

83/100

ViiV Healthcare is a biotechnological company that develops therapies for human immunodeficiency virus.

ViiV Healthcare i...
Read more